The longevity assurance homologue of yeast lag1 (Lass) gene family (review)

International Journal of Molecular Medicine

Volumn 23, Issue 2, 2009, Pages 135-140

  Teufel, Andreas ^a   Maass, Thorsten ^a   Galle, Peter R ^a   Malik, Nasir ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Apoptosis; Cancer; Ceramide; Homeodomain; Longevity; Stress response

Indexed keywords

CERAMIDE; CERAMIDE DERIVATIVE; CERAMIDE SYNTHASE; HOMEODOMAIN PROTEIN; LIPOSOME; LONGEVITY ASSURANCE PROTEIN 1; MEMBRANE PROTEIN; PROTEIN LAC1; PROTEIN LIP1; UNCLASSIFIED DRUG; DIHYDROCERAMIDE DESATURASE; LASS1 PROTEIN, HUMAN; OXIDOREDUCTASE;

AMINO ACID SEQUENCE; APOPTOSIS; BREAST ADENOCARCINOMA; CANCER INHIBITION; CANCER THERAPY; CARCINOGENESIS; CELL GROWTH; CELLULAR DISTRIBUTION; CELLULAR STRESS RESPONSE; DRUG TARGETING; ENZYME SYNTHESIS; GENETIC CONSERVATION; HUMAN; LIPOSOMAL DELIVERY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; YEAST; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; CHEMISTRY; GENETICS; METABOLISM; MOLECULAR GENETICS; NEOPLASM; PHYSIOLOGY; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANIMALS; CERAMIDES; HUMANS; MEMBRANE PROTEINS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; NEOPLASMS; OXIDOREDUCTASES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 64749098852     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000110     Document Type: Review

References (36)

1. D'Mello NP, Childress AM, Franklin DS, Kale SP, Pinswasdi C and Jazwinski SM: Cloning and characterization of LAG1, a longevity-assurance gene in yeast. J Biol Chem 269: 15451-15459, 1994.
2. Barz WP and Walter P: Two endoplasmic reticulum (ER) membrane proteins that facilitate ER-to-Golgi transport of glycosylphosphatidylinositol-anchored proteins. Mol Biol Cell 10: 1043-1059, 1999.
3. Jiang JC, Kirchman PA, Zagulski M, Hunt J and Jazwinski SM: Homologs of the yeast longevity gene LAG1 in Caenorhabditis elegans and human. Genome Res 8: 1259-1272, 1998.
4. Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J and Wheeler DL: GenBank. Nucleic Acids Res 36: D25-D30, 2008.
5. Winter E and Ponting CP: TRAM, LAG1 and CLN8: members of a novel family of lipid-sensing domains? Trends Biochem Sci 27: 381-383, 2002.
6. Venkataraman K, Riebeling C, Bodennec J, Riezman H, Allegood JC, Sullards MC, Merrill AH Jr, et al: Upstream of growth and differentiation factor 1 (uog1), a mammalian homolog of the yeast longevity assurance gene 1 (LAG1), regulates N-stearoyl-sphinganine (C18-(dihydro)ceramide) synthesis in a fumonisin B1-independent manner in mammalian cells. J Biol Chem 277: 35642-35649, 2002.
7. Vallee B and Riezman H: Lip1p: a novel subunit of acyl-CoA ceramide synthase. EMBO J 24: 730-741, 2005.
8. Venkataraman K and Futerman AH: Do longevity assurance genes containing Hox domains regulate cell development via ceramide synthesis? FEBS Lett 528: 3-4, 2002.
9. Sonnhammer EL, Eddy SR and Durbin R: Pfam: a comprehensive database of protein domain families based on seed alignments. Proteins 28: 405-420, 1997.
10. Gehring WJ, Affolter M and Burglin T: Homeodomain proteins. Annu Rev Biochem 63: 487-526, 1994.
11. Thompson JD, Higgins DG and Gibson TJ: CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22: 4673-4680, 1994.
12. Spassieva S, Seo JG, Jiang JC, Bielawski J, Alvarez-Vasquez F, Jazwinski SM, Hannun YA, et al: Necessary role for the Lag1p motif in (dihydro)ceramide synthase activity. J Biol Chem 281: 33931-33938, 2006.
13. Mizutani Y, Kihara A and Igarashi Y: Mammalian Lass6 and its related family members regulate synthesis of specific ceramides. Biochem J 390: 263-271, 2005.
14. Alonso CR: Hox proteins: sculpting body parts by activating localized cell death. Curr Biol 12: R776-R778, 2002.
15. Nunes FD, de Almeida FC, Tucci R and de Sousa SC: Homeobox genes: a molecular link between development and cancer. Pesqui Odontol Bras 17: 94-98, 2003.
16. Mesika A, Ben-Dor S, Laviad EL and Futerman AH: A new functional motif in Hox domain-containing ceramide synthases: identification of a novel region flanking the Hox and TLC domains essential for activity. J Biol Chem 282: 27366-27373, 2007.
17. Pewzner-Jung Y, Ben-Dor S and Futerman AH: When do Lasses (longevity assurance genes) become CerS (ceramide synthases)?: Insights into the regulation of ceramide synthesis. J Biol Chem 281: 25001-25005, 2006.
18. Kageyama-Yahara N and Riezman H: Transmembrane topology of ceramide synthase in yeast. Biochem J 398: 585-593, 2006.
19. Soriano JM, Gonzalez L and Catala AI: Mechanism of action of sphingolipids and their metabolites in the toxicity of fumonisin B1. Prog Lipid Res 44: 345-356, 2005.
20. Lahiri S and Futerman AH: LASS5 is a bona fide dihydroceramide synthase that selectively utilizes palmitoyl-CoA as acyl donor. J Biol Chem 280: 33735-33738, 2005.
21. Guillas I, Kirchman PA, Chuard R, Pfefferli M, Jiang JC, Jazwinski SM and Conzelmann A: C26-CoA-dependent ceramide synthesis of Saccharomyces cerevisiae is operated by Lag1p and Lac1p. EMBO J 20: 2655-2665, 2001.
22. Riebeling C, Allegood JC, Wang E, Merrill AH Jr and Futerman AH: Two mammalian longevity assurance gene (LAG1) family members, trh1 and trh4, regulate dihydroceramide synthesis using different fatty acyl-CoA donors. J Biol Chem 278: 43452-43459, 2003.
23. Schorling S, Vallee B, Barz WP, Riezman H and Oesterhelt D: Lag1p and Lac1p are essential for the Acyl-CoA-dependent ceramide synthase reaction in Saccharomyces cerevisae. Mol Biol Cell 12: 3417-3427, 2001.
24. Brandwagt BF, Mesbah LA, Takken FL, Laurent PL, Kneppers TJ, Hille J and Nijkamp HJ: A longevity assurance gene homolog of tomato mediates resistance to Alternaria alternata f. sp. lycopersici toxins and fumonisin B1. Proc Natl Acad Sci USA 97: 4961-4966, 2000.
25. Spassieva SD, Markham JE and Hille J: The plant disease resistance gene Asc-1 prevents disruption of sphingolipid metabolism during AAL-toxin-induced programmed cell death. Plant J 32: 561-572, 2002.
26. Pan H, Qin WX, Huo KK, Wan DF, Yu Y, Xu ZG, Hu QD, et al: Cloning, mapping, and characterization of a human homologue of the yeast longevity assurance gene LAG1. Genomics 77: 58-64, 2001.
27. Koybasi S, Senkal CE, Sundararaj K, Spassieva S, Bielawski J, Osta W, Day TA, et al: Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas. J Biol Chem 279: 44311-44319, 2004.
28. Hicklin DJ, Marincola FM and Ferrone S: HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story. Mol Med Today 5: 178-186, 1999.
29. Seliger B, Maeurer MJ and Ferrone S: TAP off - tumors on. Immunol Today 18: 292-299, 1997.
30. Marincola FM, Jaffee EM, Hicklin DJ and Ferrone S: Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance. Adv Immunol 74: 181-273, 2000.
31. van Hall T, Wolpert EZ, van Veelen P, Laban S, van der Veer M, Roseboom M, Bres S, et al: Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants. Nat Med 12: 417-424, 2006.
32. Senchenkov A, Litvak DA and Cabot MC: Targeting ceramide metabolism - a strategy for overcoming drug resistance. J Natl Cancer Inst 93: 347-357, 2001.
33. Reynolds CP, Maurer BJ and Kolesnick RN: Ceramide synthesis and metabolism as a target for cancer therapy. Cancer Lett 206: 169-180, 2004.
34. Modrak DE, Gold DV and Goldenberg DM: Sphingolipid targets in cancer therapy. Mol Cancer Ther 5: 200-208, 2006.
35. Stover T and Kester M: Liposomal delivery enhances short-chain ceramide-induced apoptosis of breast cancer cells. J Pharmacol Exp Ther 307: 468-475, 2003.
36. Kyttala A, Lahtinen U, Braulke T and Hofmann SL: Functional biology of the neuronal ceroid lipofuscinoses (NCL) proteins. Biochim Biophys Acta 1762: 920-933, 2006.